Medifast reported a $17.5 million Q3 2026 loss driven by restructuring, while coach productivity rose 54% and management ...
Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for the third quarter ended ...
A new study suggests that women using menopause hormone therapy alongside GLP-1 medications like Wegovy may experience greater weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results